Eli Lilly and Co. (NYSE:LLY) said Sunday that its Phase 3 BRUIN CLL-322 trial met its primary endpoint, with the addition of Jaypirca (pirtobrutinib) t...
A report on June 12, 2026 shows that Representative Julie Johnson from Texas sale stock in Abbott Laboratories (NYSE:ABT), valued between $2,002 and $3...
Cipla has appointed Shivam Puri as the new Chief Executive Officer for its One India Business. This significant leadership change will take effect from...
Eli Lilly's new JAK2 inhibitor-which it obtained from the recent acquisition of Ajax Therapeutics-reduced spleen volume by more than a third in 70% of ...
Eli Lilly and Company announced results from the Phase 3 BRUIN CLL─322 clinical trial of Jaypirca (pirtobrutinib), a non─covalent Bruton tyrosine kinas...
Acquired through its purchase of Ajax, the drug showed encouraging effects in patients with hard-to-treat myelofibrosis. To analysts, such results coul...
BRUIN CLL-322 is the first Phase 3 study to demonstrate superiority over a venetoclax-containing control arm in CLL, and, with the majority of patients...
Frequently Asked Questions about Vitamin Planet
Who are Vitamin Planet's top competitors?
Vitamin Planet's top 3 competitors are Acolyte Sports Nutrition, Go4 It Nutrition, Supranutrition.
Who is similar to Vitamin Planet?
Acolyte Sports Nutrition is the most similar to Vitamin Planet. Go4 It Nutrition and Supranutrition are also similar to Vitamin Planet.
Are Vitamin Planet and Acolyte Sports Nutrition competitors?
Yes, Acolyte Sports Nutrition is one of Vitamin Planet’s top competitors.